Delcath Systems Inc
DCTH Real Time Price USDRecent trades of DCTH by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Roger Marshall House / R | Sale $1,001 - $15,000 | Jun. 09, 2017 |
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by DCTH's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Method of selecting chemotherapeutic agents for an isolated organ or regional therapy Jan. 09, 2024
-
Patent Title: Filter and frame apparatus and method of use Dec. 05, 2023
-
Patent Title: Apparatus for removing chemotherapy compounds from blood Apr. 25, 2023
-
Patent Title: Apparatus for removing chemotherapy compounds from blood Feb. 08, 2022
-
Patent Title: Filter and frame apparatus and method of use Aug. 10, 2021
-
Patent Title: Apparatus for removing chemotherapy compounds from blood Feb. 25, 2020
-
Patent Title: Apparatus for removing chemotherapy compounds from blood Aug. 06, 2019
-
Patent Title: Filter and frame apparatus and method of use Feb. 05, 2019
-
Patent Title: Apparatus for removing chemotherapy compounds from blood Oct. 16, 2018
-
Patent Title: Apparatus for removing chemotherapy compounds from blood Jul. 18, 2017
-
Patent Title: Method of selecting chemotherapeutic agents for an isolated organ or regional therapy Jan. 10, 2017
-
Patent Title: Filter and frame apparatus and method of use Apr. 19, 2016
-
Patent Title: Dual filter Jul. 08, 2014
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of DCTH in WallStreetBets Daily Discussion
Recent insights relating to DCTH
Recent picks made for DCTH stock on CNBC
ETFs with the largest estimated holdings in DCTH
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view DCTH Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.